Cheryl Blanchard, PhD
Cheryl Blanchard is an engineer turned CEO whose career has been focused on bringing innovative medical device, biologic, regenerative medicine and drug delivery products to patients around the world. Cheryl’s career path started out in research and development and quickly morphed into leadership positions in the corporate world. Her early technical work led to the formation of a company that develops regenerative wound care technologies and later in her role as Chief Scientific Officer of Zimmer, Inc., the development of over 100 products that have impacted the lives of millions of orthopaedic patients. She also founded, built and led the Zimmer biologics business that developed a portfolio of innovative regenerative medicine products to treat a number of orthopaedic conditions. She is currently President and CEO of Keratin Biosciences, a company developing advanced wound care, regenerative medicine and drug delivery products. Cheryl also serves on the boards of a number of private and public medical technology companies. Because a strong STEM education changed her life, she also serves tirelessly as an advocate for STEM education in her community and beyond. Cheryl is humbled to have received honors including being elected a fellow of the American Institute for Medical and Biological Engineering (AIMBE) and being elected as a member of the National Academy of Engineering.